FSD Pharma (HUGE) Short Interest Ratio & Short Volume → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free HUGE Stock Alerts $0.38 +0.04 (+11.76%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media FSD Pharma Short Interest DataCurrent Short Volume334,900 sharesPrevious Short Volume374,000 sharesChange Vs. Previous Month-10.45%Dollar Volume Sold Short$136,471.75Short Interest Ratio / Days to Cover1.4Last Record DateApril 30, 2024Outstanding Shares40,120,000 sharesFloat Size33,570,000 sharesShort Percent of Float1.00%Today's Trading Volume226,814 sharesAverage Trading Volume200,414 sharesToday's Volume Vs. Average113% Short Selling FSD Pharma ? Sign up to receive the latest short interest report for FSD Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHUGE Short Interest Over TimeHUGE Days to Cover Over TimeHUGE Percentage of Float Shorted Over Time Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. FSD Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024334,900 shares $136,471.75 -10.5%1.0%1.4 $0.41 4/15/2024374,000 shares $195,564.60 +12.2%1.1%2.5 $0.52 3/31/2024333,400 shares $238,581.04 -23.6%2.1%2.6 $0.72 3/15/2024436,600 shares $312,125.34 +19.9%2.7%3.3 $0.71 2/29/2024364,200 shares $317,800.92 +26.6%2.3%3.3 $0.87 2/15/2024287,700 shares $243,106.50 -4.6%1.8%3 $0.85 Get the Latest News and Ratings for HUGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024301,700 shares $251,919.50 +2.6%1.9%2.8 $0.84 1/15/2024294,200 shares $273,811.94 -7.3%1.8%2.6 $0.93 12/31/2023317,400 shares $291,944.52 -4.9%2.0%2.9 $0.92 12/15/2023333,800 shares $337,138.00 -31.0%2.1%3 $1.01 11/30/2023483,700 shares $503,048.00 +58.9%3.0%2.7 $1.04 11/15/2023304,400 shares $353,104.00 -14.9%1.9%1.8 $1.16 10/31/2023357,800 shares $372,112.00 +10.2%2.2%2.3 $1.04 10/15/2023324,600 shares $373,290.00 -5.6%2.0%1.5 $1.15 9/30/2023343,700 shares $416,083.22 +9.9%2.1%1.7 $1.21 9/15/2023312,800 shares $469,200.00 -2.6%2.0%1.5 $1.50 8/31/2023321,000 shares $407,670.00 -3.7%2.0%2.5 $1.27 8/15/2023333,400 shares $476,762.00 -22.1%2.1%2.5 $1.43 7/31/2023427,800 shares $496,248.00 -6.3%2.7%3.7 $1.16 7/15/2023456,700 shares $534,339.00 -2.9%2.9%7.3 $1.17 6/30/2023470,400 shares $540,960.00 +13.1%2.9%5 $1.15 6/15/2023415,900 shares $478,285.00 -7.8%2.6%4.1 $1.15 5/31/2023450,900 shares $482,463.00 -8.8%2.8%4.2 $1.07 5/15/2023494,300 shares $548,673.00 -5.1%3.1%3.7 $1.11 4/30/2023520,800 shares $775,992.00 +13.4%3.3%3.1 $1.49 4/15/2023459,300 shares $854,298.00 +26.4%2.9%2.6 $1.86 3/31/2023363,300 shares $563,115.00 +6.5%2.2%2.1 $1.55 3/15/2023341,100 shares $446,841.00 -25.3%2.1%2.2 $1.31 2/28/2023456,800 shares $803,968.00 +37.4%2.8%3.1 $1.76 2/15/2023332,500 shares $571,900.00 +9.4%2.1%2.5 $1.72 1/31/2023304,000 shares $325,280.00 +0.2%1.9%2.9 $1.07 1/15/2023303,300 shares $284,192.10 -4.3%1.7%3.6 $0.94 12/30/2022317,000 shares $249,922.80 -1.4%1.8%4.9 $0.79 12/15/2022321,500 shares $258,711.05 +3.3%1.8%4.8 $0.80 11/30/2022311,200 shares $263,897.60 -8.6%1.8%4.7 $0.85 11/15/2022340,400 shares $336,996.00 -20.6%1.9%5.1 $0.99 10/31/2022428,700 shares $364,309.26 +3.3%2.5%7.4 $0.85 10/15/2022414,900 shares $333,081.72 -2.1%2.4%8.4 $0.80 9/30/2022423,700 shares $349,552.50 +11.6%2.5%7.7 $0.83 9/15/2022379,800 shares $334,717.74 -1.6%2.2%6.7 $0.88Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. HUGE Short Interest - Frequently Asked Questions What is FSD Pharma's current short interest? Short interest is the volume of FSD Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 334,900 shares of HUGE short. 1.00% of FSD Pharma's shares are currently sold short. Learn More on FSD Pharma's current short interest. What is a good short interest ratio for FSD Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUGE shares currently have a short interest ratio of 1.0. Learn More on FSD Pharma's short interest ratio. What is a good short interest percentage for FSD Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.00% of FSD Pharma's floating shares are currently sold short. Is FSD Pharma's short interest increasing or decreasing? FSD Pharma saw a drop in short interest in April. As of April 30th, there was short interest totaling 334,900 shares, a drop of 10.5% from the previous total of 374,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is FSD Pharma's float size? FSD Pharma currently has issued a total of 40,120,000 shares. Some of FSD Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. FSD Pharma currently has a public float of 33,570,000 shares. How does FSD Pharma's short interest compare to its competitors? 1.00% of FSD Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to FSD Pharma: Edesa Biotech, Inc. (0.69%), Pieris Pharmaceuticals, Inc. (1.12%), Avalo Therapeutics, Inc. (10.13%), RedHill Biopharma Ltd. (2.38%), Monopar Therapeutics Inc. (1.24%), Kiora Pharmaceuticals, Inc. (0.56%), Cocrystal Pharma, Inc. (0.11%), Purple Biotech Ltd (1.18%), Tonix Pharmaceuticals Holding Corp. (1.89%), Vaxxinity, Inc. (3.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short FSD Pharma stock? Short selling HUGE is an investing strategy that aims to generate trading profit from FSD Pharma as its price is falling. HUGE shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against FSD Pharma? A short squeeze for FSD Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HUGE, which in turn drives the price of the stock up even further. How often is FSD Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUGE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Edesa Biotech Short Interest Pieris Pharmaceuticals Short Interest Avalo Therapeutics Short Interest RedHill Biopharma Short Interest Monopar Therapeutics Short Interest Kiora Pharmaceuticals Short Interest Cocrystal Pharma Short Interest Purple Biotech Short Interest Tonix Pharmaceuticals Short Interest Vaxxinity Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HUGE) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressNo experience to confident trader, meet my student…Wealth Builders InstituteThe only AI company you should be looking atBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing